JP2022525318A5 - - Google Patents
Info
- Publication number
- JP2022525318A5 JP2022525318A5 JP2021555228A JP2021555228A JP2022525318A5 JP 2022525318 A5 JP2022525318 A5 JP 2022525318A5 JP 2021555228 A JP2021555228 A JP 2021555228A JP 2021555228 A JP2021555228 A JP 2021555228A JP 2022525318 A5 JP2022525318 A5 JP 2022525318A5
- Authority
- JP
- Japan
- Prior art keywords
- cell
- chimeric antigen
- amino acid
- antigen receptor
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024194375A JP2025013530A (ja) | 2019-03-15 | 2024-11-06 | Cd147キメラ抗原受容体および使用の方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962819403P | 2019-03-15 | 2019-03-15 | |
| US62/819,403 | 2019-03-15 | ||
| PCT/US2020/020436 WO2020190483A1 (en) | 2019-03-15 | 2020-02-28 | Cd147 chimeric antigen receptors and methods of use |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024194375A Division JP2025013530A (ja) | 2019-03-15 | 2024-11-06 | Cd147キメラ抗原受容体および使用の方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022525318A JP2022525318A (ja) | 2022-05-12 |
| JP2022525318A5 true JP2022525318A5 (cg-RX-API-DMAC7.html) | 2023-02-24 |
| JP7602803B2 JP7602803B2 (ja) | 2024-12-19 |
Family
ID=72520374
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021555228A Active JP7602803B2 (ja) | 2019-03-15 | 2020-02-28 | Cd147キメラ抗原受容体および使用の方法 |
| JP2024194375A Withdrawn JP2025013530A (ja) | 2019-03-15 | 2024-11-06 | Cd147キメラ抗原受容体および使用の方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024194375A Withdrawn JP2025013530A (ja) | 2019-03-15 | 2024-11-06 | Cd147キメラ抗原受容体および使用の方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US12624102B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3938402A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7602803B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN113853390B (cg-RX-API-DMAC7.html) |
| CA (1) | CA3132458A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020190483A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20240277841A2 (en) * | 2020-12-11 | 2024-08-22 | Purdue Research Foundation | Human chimeric antigen receptor neutrophils, compositions, kits and methods of use |
| EP4268991A4 (en) * | 2020-12-22 | 2024-10-30 | Araki Technical And Research Co., Ltd. | DEVICE FOR PRODUCING A BRANCHING PARTIAL STRUCTURE IN A METAL PIPE AND METHOD FOR PRODUCING A BRANCHING PARTIAL STRUCTURE IN A METAL PIPE |
| AU2023213691A1 (en) * | 2022-01-28 | 2024-09-05 | A2 Biotherapeutics, Inc. | Compositions and methods for treating mesothelin positive cancers |
| WO2024220483A2 (en) * | 2023-04-19 | 2024-10-24 | Rutgers, The State University Of New Jersey | Grp78 chimeric antigen receptors and combination therapies for treating cancer |
| CN122206712A (zh) * | 2023-11-15 | 2026-06-12 | 国立大学法人大阪大学 | 嵌合抗原受体 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU7333794A (en) * | 1993-08-02 | 1995-02-28 | Houston Biotechnology Incorporated | Single-chain immunotoxin compositions and methods for preventing secondary cataracts |
| WO2010036460A2 (en) | 2008-09-29 | 2010-04-01 | Centocor Ortho Biotech Inc. | Anti-cd147 antibodies, methods, and uses |
| EP3250602A1 (en) * | 2015-01-26 | 2017-12-06 | Cellectis | T cell receptor knock out engineered immune cells, endowed with chimeric antigen receptors binding to cd123 for the treatment of relapsed/refractory acute myeloid lymphoma or blastic plasmacytoid dendritic cell neoplasm |
| AU2016274989A1 (en) | 2015-06-12 | 2017-11-02 | Immunomedics, Inc. | Disease therapy with chimeric antigen receptor (car) constructs and t cells (car-t) or nk cells (car-nk) expressing car constructs |
| CN107709356A (zh) * | 2015-06-26 | 2018-02-16 | 南加利福尼亚大学 | 用于肿瘤特异性活化的掩蔽嵌合抗原受体t细胞 |
| US20200231652A1 (en) * | 2015-08-31 | 2020-07-23 | National Research Council Of Canada | Tgf-b-receptor ectodomain fusion molecules and uses thereof |
| JP2020511130A (ja) * | 2017-03-09 | 2020-04-16 | サイトメックス セラピューティクス インコーポレイテッド | Cd147抗体、活性化可能cd147抗体、ならびにその作製および使用の方法 |
-
2020
- 2020-02-28 WO PCT/US2020/020436 patent/WO2020190483A1/en not_active Ceased
- 2020-02-28 JP JP2021555228A patent/JP7602803B2/ja active Active
- 2020-02-28 CN CN202080035700.8A patent/CN113853390B/zh active Active
- 2020-02-28 US US17/438,741 patent/US12624102B2/en active Active
- 2020-02-28 EP EP20773750.3A patent/EP3938402A4/en active Pending
- 2020-02-28 CA CA3132458A patent/CA3132458A1/en active Pending
-
2024
- 2024-11-06 JP JP2024194375A patent/JP2025013530A/ja not_active Withdrawn